Clinical Trial Update: A Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151) [Phase 3]

View source ↗

Summary

Phase 3 IMpower151 trial evaluating bevacizumab with chemotherapy, with or without atezolizumab, in chemo-naïve stage IV non-squamous non-small cell lung cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Avastin (bevacizumab)
• CARBOPLATIN (Carboplatin)
• Taxol (paclitaxel)
• Tecentriq (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 3 | Status: COMPLETED